Nureca Limited (NURECA) - Total Assets
Based on the latest financial reports, Nureca Limited (NURECA) holds total assets worth Rs2.25 Billion INR (≈ $24.30 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Nureca Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Nureca Limited - Total Assets Trend (2017–2025)
This chart illustrates how Nureca Limited's total assets have evolved over time, based on quarterly financial data. Check Nureca Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Nureca Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Nureca Limited's total assets of Rs2.25 Billion consist of 90.5% current assets and 9.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 1.5% |
| Accounts Receivable | Rs51.48 Million | 2.5% |
| Inventory | Rs399.18 Million | 19.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs19.83 Million | 0.9% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Nureca Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NURECA stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nureca Limited's current assets represent 90.5% of total assets in 2025, a decrease from 92.6% in 2017.
- Cash Position: Cash and equivalents constituted 1.5% of total assets in 2025, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 19.0% of total assets.
Nureca Limited Competitors by Total Assets
Key competitors of Nureca Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
Nureca Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.16 | 11.75 | 2.17 |
| Quick Ratio | 6.32 | 10.07 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs1.69 Billion | Rs1.77 Billion | Rs532.99 Million |
Nureca Limited - Advanced Valuation Insights
This section examines the relationship between Nureca Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.41 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | Rs2.10 Billion |
| Market Capitalization | $24.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nureca Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nureca Limited's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nureca Limited (2017–2025)
The table below shows the annual total assets of Nureca Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs2.10 Billion ≈ $22.71 Million |
+2.34% |
| 2024-03-31 | Rs2.05 Billion ≈ $22.19 Million |
-0.68% |
| 2023-03-31 | Rs2.07 Billion ≈ $22.34 Million |
-5.73% |
| 2022-03-31 | Rs2.19 Billion ≈ $23.70 Million |
+17.97% |
| 2021-03-31 | Rs1.86 Billion ≈ $20.09 Million |
+448.22% |
| 2020-03-31 | Rs338.83 Million ≈ $3.66 Million |
+44.04% |
| 2019-03-31 | Rs235.23 Million ≈ $2.54 Million |
+235.13% |
| 2018-03-31 | Rs70.19 Million ≈ $759.08K |
+8376.81% |
| 2017-03-31 | Rs828.02K ≈ $8.95K |
-- |
About Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more